Table 2 Primary and secondary outcomes
Analysis group | Odds ratio | 95 % confidence interval | p (alpha level 0.05) | |
|---|---|---|---|---|
Mortality | ||||
(i) Clearers/nonclearers | Unadjusted OR | 0.44 | (0.24–0.78) | 0.005 |
(ii) Clearers/nonclearers | OR adjusted for SOFA | 0.45 | (0.24–0.85) | 0.014 |
(iii) Clearers/nonclearers | OR adjusted SOFA, EGFR, and MELD | 0.39 | (0.20–0.76) | 0.006 |
Receipt of IV fluids | ||||
(i) Clearers/nonclearers | Unadjusted OR | 0.72 | (0.43–1.22) | 0.22 |
(ii) Clearers/nonclearers | OR adjusted for SOFA | 0.74 | (0.44–1.26) | 0.27 |
(iii) Clearers/Nonclearers | OR adjusted SOFA, EGFR, and MELD | 0.81 | (0.48–1.39) | 0.45 |
Receipt of vasopressors | ||||
(i) Clearers/nonclearers | Unadjusted OR | 0.46 | (0.27–0.79) | 0.005 |
(ii) Clearers/nonclearers | OR adjusted for SOFA | 0.43 | (0.23–0.83) | 0.012 |
(iii) Clearers/nonclearers | OR adjusted SOFA, EGFR, and MELD | 0.41 | (0.21–0.79) | 0.008 |